ARDS Management in the ICU
The cornerstone of ARDS management in the ICU is lung-protective mechanical ventilation with tidal volumes of 4-8 ml/kg predicted body weight and plateau pressures <30 cmH₂O, combined with severity-based adjunctive therapies including prone positioning for severe cases, higher PEEP strategies for moderate-to-severe disease, and consideration of corticosteroids and neuromuscular blockade in early severe ARDS. 1, 2
Mechanical Ventilation Strategy
Fundamental Ventilator Settings
- Maintain tidal volume at 4-8 ml/kg predicted body weight - this is the single most important intervention and applies to all ARDS severity levels 1, 2, 3
- Limit plateau pressure to <30 cmH₂O, ideally <28 cmH₂O to minimize ventilator-induced lung injury 2, 3
- Monitor and minimize driving pressure (plateau pressure minus PEEP), as this correlates directly with mortality 2, 3
- Target PaO₂ of 70-90 mmHg or SpO₂ of 92-97% to avoid oxygen toxicity while ensuring adequate tissue oxygenation 2, 3
PEEP Strategy Based on Severity
- For moderate-to-severe ARDS (PaO₂/FiO₂ ≤200 mmHg): Use higher PEEP guided by the ARDS Network PEEP-to-FiO₂ grid without prolonged recruitment maneuvers 1, 4, 2
- For mild ARDS (PaO₂/FiO₂ 200-300 mmHg): Use lower PEEP (typically 5-10 cmH₂O), as higher PEEP shows no benefit and potential harm in this population 3
- Consider esophageal pressure measurement to guide PEEP selection in complex cases 2
Severity-Based Adjunctive Therapies
For Severe ARDS (PaO₂/FiO₂ <100 mmHg)
- Implement prone positioning for >12 hours daily - this is a strong recommendation that reduces mortality in severe ARDS 1, 4, 2
- Consider neuromuscular blockade with cisatracurium for 48 hours in early severe ARDS to improve ventilator synchrony and potentially reduce mortality 1, 4
- Consider corticosteroids when initiated early in the disease course, as this may reduce mortality in moderate-to-severe ARDS 1, 4
- Do NOT initiate corticosteroids >14 days after ARDS onset, as late administration is associated with harm 4
Interventions NOT Indicated for Mild ARDS
- Do not routinely use prone positioning in mild ARDS - this intervention is specifically for severe disease only 3
- Do not routinely use neuromuscular blocking agents in mild ARDS - the recommendation applies only to early severe ARDS 3
- Avoid applying high PEEP strategies from moderate-severe protocols to mild ARDS patients, as this may cause harm without benefit 3
Fluid and Hemodynamic Management
- Implement conservative fluid management strategy once shock is resolved to avoid worsening pulmonary edema 2, 3
- Monitor right ventricular function with echocardiography to detect acute cor pulmonale, which occurs in 20-25% of ARDS patients 4, 2
- If acute cor pulmonale is identified: avoid further fluid administration and initiate norepinephrine to restore mean arterial pressure ≥65 mmHg 4
- Optimize oxygenation aggressively, as hypoxemia increases pulmonary vascular resistance and RV afterload 4
- Consider reducing PEEP if RV dysfunction is severe, as high airway pressures can adversely affect RV function 4, 2
Sedation and Ventilator Synchrony
- Titrate sedation according to protocols with regular drug interruption 1
- As oxygenation improves and FiO₂/PEEP can be reduced, stop or reduce sedation and assess for weaning readiness 1
- Ensure patient-ventilator synchrony, as even assisted ventilation can induce ventilator-induced lung injury through high tidal volumes and transpulmonary pressures 1
Rescue Therapy for Refractory Severe ARDS
- Consider venovenous ECMO as last resort if PaO₂/FiO₂ remains <70 mmHg for ≥3 hours or <100 mmHg for ≥6 hours despite optimized ventilation, prone positioning, and neuromuscular blockade 4
- ECMO probably decreases mortality and increases ventilator-free days in severe ARDS, though it requires expertise and careful patient selection 1, 4
- ECMO should be reserved for the most severe cases and carried out in experienced ECMO centers 1
Weaning and Liberation from Mechanical Ventilation
- Perform daily spontaneous breathing trials (SBT) as the central component of weaning protocol, as this consistently reduces duration of mechanical ventilation 1
- Use T-piece, CPAP, or low levels of pressure support ventilation for SBT, though clinical data comparing these methods are inconsistent 1
- For patients at high risk for extubation failure, use NIV after extubation, as this may significantly reduce ICU length of stay and mortality 1
- For patients with high risk of lung collapse (morbid obesity, post-cardiac surgery), consider direct extubation from CPAP levels ≥10 cmH₂O, as this reduces postoperative pulmonary complications 1
Tracheostomy Considerations
- Consider tracheostomy when prolonged mechanical ventilation is anticipated, but do not use routinely in every ARDS patient 1
- Early tracheostomy may be associated with higher survival rates, though this may be due primarily to earlier ICU discharge 1
Monitoring and Supportive Care
- Continuously assess oxygenation using PaO₂/FiO₂ ratio to detect progression between ARDS severity categories 3
- Perform serial assessments of plateau pressure with end-inspiratory pauses (0.3-0.5 seconds) to confirm lung-protective ventilation 3
- Monitor for auto-PEEP by examining expiratory flow waveforms to ensure complete exhalation 3
- Elevate head of bed ≥30 degrees to reduce aspiration risk 3
- Provide stress ulcer prophylaxis and venous thromboembolism prophylaxis 3
- Initiate early enteral nutrition with formulations containing antioxidants and anti-inflammatory amino acids, which may improve gas exchange 3
Critical Pitfalls to Avoid
- Never allow tidal volumes to exceed 8 ml/kg predicted body weight, even if this requires accepting permissive hypercapnia, as ventilator-induced lung injury significantly worsens outcomes 3
- Do not use inhaled nitric oxide routinely - it is not indicated for ARDS management and has not been shown to improve outcomes 5, 6
- Avoid high frequency oscillation - this is not recommended for ARDS 6
- Investigate sudden clinical deterioration aggressively with CT pulmonary angiography or bedside echocardiography to evaluate for pulmonary embolism, and rule out pneumothorax with chest imaging 4